[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5186 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 5186

To authorize the Secretary of Defense to carry out a program to support 
    the defense biotechnology supply chain, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 8, 2025

    Mr. Khanna (for himself, Mr. Garamendi, and Mr. Davis of North 
  Carolina) introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
To authorize the Secretary of Defense to carry out a program to support 
    the defense biotechnology supply chain, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. BIOTECHNOLOGY SUPPLY CHAIN RESILIENCY PROGRAM.

    (a) Authorization.--
            (1) In general.--The Secretary of Defense, in coordination 
        with the Secretaries of the military departments and the heads 
        of relevant Defense Agencies, may establish and implement a 
        program (referred to in this section as the ``Program'') to 
        develop, scale, and transition biotechnology research from the 
        military service laboratories, including biotechnology-based 
        chemicals, materials, fuels, and other products relevant to the 
        mission of the Department of Defense that support the 
        resilience, sustainability, and responsiveness of the defense 
        supply chain.
            (2) Activities.--Under the Program, the Secretary of 
        Defense may carry out the following activities:
                    (A) Conduct an assessment of supply chain 
                vulnerabilities in the Department of Defense.
                    (B) Direct the military service laboratories to 
                establish mechanisms to collaboratively--
                            (i) conduct applied research, including 
                        experimentation, advanced technological 
                        development, advanced component development, 
                        and rapid prototyping in bioindustrials, 
                        biomanufacturing, and related disciplines to 
                        support defense missions;
                            (ii) develop, prototype, test, and 
                        transition biologically derived materials and 
                        products to reduce reliance on foreign supply 
                        chains and vulnerable supply chains;
                            (iii) upgrade, expand, or construct 
                        physical and digital infrastructure, including 
                        laboratory facilities, of the Department and 
                        its partners to support bioindustrial research, 
                        development, testing, prototyping, and 
                        production;
                            (iv) as needed, enter into contracts, 
                        cooperative agreements, grants, or other 
                        transactions with relevant Federal entities and 
                        non-Federal entities such as commercial 
                        entities, research institutions, and academic 
                        organizations to execute the activities under 
                        this paragraph; and
                            (v) support education, training, and 
                        workforce development initiatives to build and 
                        sustain a skilled bioindustrial and 
                        biomanufacturing workforce.
                    (C) Collaborate across the military departments, 
                Defense Agencies, and other Federal entities to ensure 
                alignment with national bioindustrial and supply chain 
                strategies.
                    (D) Promote the development and utilization of 
                next-generation feedstocks and processes in ways that 
                support local economic growth.
                    (E) Modernize infrastructure through investment in 
                facilities that enable rapid prototyping and advanced 
                materials testing.
                    (F) Establish performance metrics and benchmarks to 
                measure progress toward operational integration and 
                transition to programs of record.
            (3) Other considerations.--In the event the Secretary 
        carries out the Program, the Secretary of Defense shall--
                    (A) prioritize technologies and capabilities that 
                address critical defense supply chain vulnerabilities 
                and enhance military readiness, including technologies 
                and capabilities necessary to--
                            (i) reduce logistics through field-enabled 
                        manufacturing of materials such as 
                        construction-grade bio-cement and deployable 
                        infrastructure components;
                            (ii) enhance performance through 
                        development of novel materials including 
                        protective coatings and biologically derived 
                        composites; or
                            (iii) improve cost efficiency of 
                        manufacturing and reduce dependency on foreign 
                        supply chains;
                    (B) consult with representatives of industry, 
                academia, and other Federal agencies with relevant 
                expertise, to accelerate development and transitions; 
                and
                    (C) ensure the Program supports the development and 
                fielding of emerging technologies such as 
                biotechnologies that provide operational and strategic 
                advantages to the Armed Forces, including through--
                            (i) cross-service and public-private 
                        partnerships; and
                            (ii) applied research, pilot-scale 
                        production, and technology transition efforts 
                        focused on biomanufacturing and materials 
                        innovation.
    (b) Plan and Reports.--
            (1) Initial plan.--Not later than 90 days after electing to 
        commence the Program, the Secretary of Defense shall submit to 
        the Committees on Armed Services of the Senate and the House of 
        Representatives a plan for the allocation of appropriations to 
        fund the Program.
            (2) Annual reports.--Not later than one year after 
        commencing the Program, and annually thereafter until the 
        Program terminates under subsection (c), the Secretary of 
        Defense shall submit to the Committees on Armed Services of the 
        Senate and the House of Representatives a report detailing all 
        activities carried out under the program. Each report shall 
        include, to the extent applicable, the following:
                    (A) A summary of key research, development, and 
                prototyping efforts initiated or continued during the 
                year covered by the report, including technical 
                objectives, anticipated defense applications, and 
                funding.
                    (B) A list of significant partnerships or 
                agreements executed with industry, academic 
                institutions, and other Federal agencies, including the 
                purpose, national security nexus, and funding level of 
                each such partnership or agreement.
                    (C) An assessment of infrastructure enhancements 
                undertaken to support bioindustrial development and 
                scale-up, including facility modernization and 
                equipment acquisition.
                    (D) An evaluation of program performance against 
                established milestones or metrics, including progress 
                toward the transition of technologies to operational 
                use or acquisition programs.
                    (E) An identification of major technical, 
                logistical, or policy challenges encountered, and 
                actions taken to mitigate such challenges.
                    (F) Any recommendations for additional authorities, 
                funding mechanisms, or interagency coordination 
                necessary to enhance the effectiveness of the Program.
            (3) Form.--Each report under this subsection shall be 
        submitted in unclassified form but may contain a classified 
        annex.
    (c) Sunset.--
            (1) In general.--Except as provided in paragraph (2), the 
        authority to carry out the Program shall terminate on the date 
        that is 10 years after the date of the enactment of this Act.
            (2) Extension.--The Program may be continued after the 
        termination date specified in paragraph (1) if, before such 
        date, the President--
                    (A) determines that continuation of the Program is 
                necessary to meet national economic or national 
                security needs; and
                    (B) submits notice of such determination to the 
                Committees on Armed Services of the Senate and the 
                House of Representatives.
                                 <all>